Tern Plc announces 63% take-up of Open Offer

TERN

Tern Plc (LON:TERN), the Company focused on value creation from Internet of Things technology businesses, has announced the results of its Open Offer to Qualifying Shareholders which was announced on 21 April 2026 and closed for acceptances, in accordance with its terms, on 7 May 2026.

The Company announces that valid acceptances have been received from Qualifying Shareholders for a total of 67,666,314 new Ordinary Shares under the Open Offer, representing a take-up of approximately 63% of the 107,268,195 Open Offer Shares available.

The Open Offer is conditional upon the passing of the Resolutions at a General Meeting being held at 11.00 a.m. today, 8 May 2026, and Admission of the Open Offer Shares to trading on AIM. Subject to the passing of the Resolutions, the Open Offer will raise gross proceeds of approximately £406,000 for the Company and it is expected that Admission will become effective and dealings in the Open Offer Shares on AIM will commence on 11 May 2026.

A further announcement will be made following the conclusion of the General Meeting.

Capitalised terms used but not otherwise defined in this announcement bear the meanings ascribed to them in the circular posted to shareholders on 21 April 2026.

Director and PDMR participation in the Open Offer

The following Director and persons discharging managerial responsibilities (“PDMRs“) of the Company have opted to participate in the Open Offer, and conditional upon the passing of the Resolutions at the General Meeting and Admission will subscribe for the Open Offer Shares as follows:

DirectorNumber of Existing Ordinary SharesNumber of Open Offer Shares subscribed forNumber of Ordinary Shares to be held on Admission% of the Enlarged Share Capital to be held on Admission
Iain Ross1,843,808263,4012,107,2090.26%
PDMRNumber of Existing Ordinary SharesNumber of Open Offer Shares subscribed forNumber of Ordinary Shares to be held on Admission% of the Enlarged Share Capital to be held on Admission
Albert Sisto21,126,0961,500,39422,626,4902.76%

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Evidence-based care pathways support more consistent healthcare delivery

Evidence-based care pathways can improve diagnosis, treatment consistency and the integration of new therapies into routine care.

Tern increases Talking Medicines funding and raises shareholder distribution commitment

Tern has invested in additional Talking Medicines convertible loan notes and increased its minimum shareholder distribution commitment to 70% on qualifying exits.

Evidence-based care pathways create clearer routes to adoption

Evidence-based care pathways can reduce delays, improve treatment consistency and support the adoption of new therapies.

Talking Medicines highlights the data opportunity emerging around GLP-1 care

Talking Medicines examines how the expanding GLP-1 market is increasing the importance of clear distinctions between approved therapies, compounded medicines and nutritional support.

Tern plc raises £450,000 in share placing ahead of AIM admission

Tern plc has raised £450,000 through a placing and outlined expected admission timing and updated voting rights.

AI search makes message measurement a healthcare priority

As AI changes search, healthcare companies need to know whether their messages are being seen, understood and represented correctly.

Search